167 related articles for article (PubMed ID: 26898438)
1. Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression.
Wang L; Guo XL
Biomed Pharmacother; 2016 Mar; 78():165-171. PubMed ID: 26898438
[TBL] [Abstract][Full Text] [Related]
2. On the role of galectin-3 in cancer apoptosis.
Nakahara S; Oka N; Raz A
Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3--a jack-of-all-trades in cancer.
Newlaczyl AU; Yu LG
Cancer Lett; 2011 Dec; 313(2):123-8. PubMed ID: 21974805
[TBL] [Abstract][Full Text] [Related]
4. Roles of galectin-3 in metabolic disorders and tumor cell metabolism.
Li YS; Li XT; Yu LG; Wang L; Shi ZY; Guo XL
Int J Biol Macromol; 2020 Jan; 142():463-473. PubMed ID: 31604080
[TBL] [Abstract][Full Text] [Related]
5. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner.
Kim SJ; Chun KH
BMB Rep; 2020 Apr; 53(4):173-180. PubMed ID: 32172730
[TBL] [Abstract][Full Text] [Related]
6. Role of the interaction between galectin-3 and cell adhesion molecules in cancer metastasis.
Xin M; Dong XW; Guo XL
Biomed Pharmacother; 2015 Feb; 69():179-85. PubMed ID: 25661355
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 and metastasis.
Takenaka Y; Fukumori T; Raz A
Glycoconj J; 2002; 19(7-9):543-9. PubMed ID: 14758078
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
9. Galectin 3 as a guardian of the tumor microenvironment.
Ruvolo PP
Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.
de Oliveira JT; Ribeiro C; Barros R; Gomes C; de Matos AJ; Reis CA; Rutteman GR; Gärtner F
PLoS One; 2015; 10(7):e0134458. PubMed ID: 26222311
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma.
Junking M; Wongkham C; Sripa B; Sawanyawisuth K; Araki N; Wongkham S
Eur J Cancer; 2008 Mar; 44(4):619-26. PubMed ID: 18272359
[TBL] [Abstract][Full Text] [Related]
12. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients).
Arfaoui-Toumi A; Kria-Ben Mahmoud L; Ben Hmida M; Khalfallah MT; Regaya-Mzabi S; Bouraoui S
Bull Cancer; 2010 Feb; 97(2):E1-8. PubMed ID: 20080461
[TBL] [Abstract][Full Text] [Related]
13. [Cancer-associated carbohydrate-binding protein galectin-3 and its therapeutic ligands].
Bai H; Liu L; Li YH; You Y; Mei QB
Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):129-34. PubMed ID: 18664176
[TBL] [Abstract][Full Text] [Related]
14. Identification and consequences of galectin-3 expression in pituitary tumors.
Righi A; Jin L; Zhang S; Stilling G; Scheithauer BW; Kovacs K; Lloyd RV
Mol Cell Endocrinol; 2010 Sep; 326(1-2):8-14. PubMed ID: 20451577
[TBL] [Abstract][Full Text] [Related]
15. Nuclear transport of galectin-3 and its therapeutic implications.
Funasaka T; Raz A; Nangia-Makker P
Semin Cancer Biol; 2014 Aug; 27():30-8. PubMed ID: 24657939
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 as a multifunctional protein.
Krześlak A; Lipińska A
Cell Mol Biol Lett; 2004; 9(2):305-28. PubMed ID: 15213811
[TBL] [Abstract][Full Text] [Related]
17. Immunhistochemical expression of galectin-3 in cancer: a review of the literature.
Cay T
Turk Patoloji Derg; 2012; 28(1):1-10. PubMed ID: 22207425
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway.
Nakahara S; Raz A
Cancer Metastasis Rev; 2007 Dec; 26(3-4):605-10. PubMed ID: 17726578
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 in cancer.
Song L; Tang JW; Owusu L; Sun MZ; Wu J; Zhang J
Clin Chim Acta; 2014 Apr; 431():185-91. PubMed ID: 24530298
[TBL] [Abstract][Full Text] [Related]
20. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
